PADI4 and neoplasm: Subsequently, Zhu et al. [75] further developed a range of highly targeted PBA-PAD4 inhibitors against tumor cells, using phenylboronic acid to modify the PAD4 inhibitors so that they could be specifically taken up by tumor cells.